최소 침습 수술 기구 시장 기회, 성장 요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Minimally Invasive Surgical Instrument Market was valued at USD 31.6 billion in 2025 and is estimated to grow at a CAGR of 7.4% to reach USD 66.1 billion by 2035.

The market is propelled by a surge in demand for less invasive surgical procedures, wider adoption of robotic-assisted surgeries, ongoing technological innovation, and the increasing prevalence of chronic conditions. Aging populations and the rising trend of outpatient surgeries in developed countries are further supporting market expansion. Recent developments in surgical instruments have expanded the range of minimally invasive procedures across multiple specialties. Technologies such as haptic feedback have enhanced surgeons' tactile perception, while disposable advanced energy devices improve sterility and cost-effectiveness for healthcare facilities. Robotic-assisted platforms have become widely accessible, allowing procedures once limited to open surgeries to now be performed minimally invasively. Overall, the combination of advanced instrumentation, procedural efficiency, and hospital cost-saving benefits is driving the adoption of these technologies globally.

The handheld instruments segment held a 23.7% share in 2025. Innovations in these devices focus on ergonomics, increased articulation for hard-to-reach anatomical areas, and the use of lightweight, durable materials like titanium alloys and advanced polymers. Core handheld tools include laparoscopic graspers, scissors, needle holders, and other specialty instruments. Emphasis on disposable and infection-free instruments is also supporting growth in this category.

The cardiothoracic surgery segment reached USD 7.5 billion in 2025. Minimally invasive cardiac procedures typically use smaller incisions rather than traditional approaches, reducing recovery times, infection risk, and functional limitations. Robotic-assisted platforms provide three-dimensional visualization and enhanced instrument articulation, enabling precise procedures such as valve repairs to be conducted more efficiently and safely.

U.S. Minimally Invasive Surgical Instrument Market was valued at USD 11.6 billion in 2025. Growth in the region is fueled by high per-capita healthcare spending, sophisticated reimbursement systems, and early adoption of cutting-edge medical technologies. The widespread coverage of minimally invasive procedures by private insurance and Medicare supports demand across multiple surgical specialties. Additionally, healthcare providers recognize the cost benefits of shorter hospital stays and improved patient outcomes, encouraging investment in minimally invasive infrastructure.

Key players in the Global Minimally Invasive Surgical Instrument Market include Johnson & Johnson MedTech, Intuitive Surgical Operations, Medtronic, B. Braun, Boston Scientific, Stryker, Abbott, OLYMPUS, Smith + Nephew, Becton, Dickinson and Company, KARL STORZ, ZIMMER BIOMET, WEXLER SURGICAL, FUJIFILM, and Biorad Medisys. Market leaders adopt several strategies to strengthen their presence. They focus heavily on research and development to launch advanced, ergonomically designed instruments and integrate robotic-assisted technology. Companies expand both direct and indirect distribution networks while forming strategic collaborations with hospitals and surgical centers to increase adoption. Marketing campaigns highlight clinical efficacy, procedural efficiency, and cost benefits, while training programs ensure surgeon proficiency with new devices. Firms also pursue mergers, acquisitions, and geographic expansion to gain market share and enhance global competitiveness, leveraging innovation and strong brand recognition to maintain leadership in the rapidly growing minimally invasive surgical instruments sector.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Surgery type trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of chronic diseases
    • 3.2.1.2 Technological advancements in surgical instruments
    • 3.2.1.3 Growing adoption of robotic-assisted surgeries
    • 3.2.1.4 Surging demand for minimally invasive procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of surgical instruments
    • 3.2.2.2 Reimbursement challenges in developing countries
  • 3.2.3 Opportunities
    • 3.2.3.1 Technological innovations in electrosurgical and energy devices
    • 3.2.3.2 Expansion of tele-surgery and remote-assisted operations
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 MEA
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Pricing analysis
• 3.7 Reimbursement scenario
  • 3.7.1 North America
  • 3.7.2 Europe
  • 3.7.3 Asia Pacific
• 3.8 Policy landscape
• 3.9 Supply chain analysis
• 3.10 Environmental and sustainability initiatives
• 3.11 Investment opportunities and venture capital trends
• 3.12 Porter's analysis
• 3.13 PESTEL analysis
• 3.14 Gap analysis
• 3.15 Future market trends

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Handheld instruments
  • 5.2.1 Graspers
  • 5.2.2 Retractors/elevators
  • 5.2.3 Dilators
  • 5.2.4 Suturing instruments
  • 5.2.5 Other handheld instruments
• 5.3 Monitoring & visualization devices
• 5.4 Surgical scopes
  • 5.4.1 Laparoscopes
  • 5.4.2 Arthroscopes
  • 5.4.3 Urology endoscopes
  • 5.4.4 Neuroendoscopes
  • 5.4.5 Other scopes
• 5.5 Inflation devices
• 5.6 Cutter instruments
• 5.7 Guiding devices
  • 5.7.1 Guiding catheters
  • 5.7.2 Guidewires
• 5.8 Auxiliary devices
• 5.9 Electrosurgical devices

Chapter 6 Market Estimates and Forecast, By Surgery Type, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Cardiothoracic surgery
• 6.3 Orthopedic surgery
• 6.4 Gastrointestinal surgery
• 6.5 Urological surgery
• 6.6 Gynecological surgery
• 6.7 Cosmetic & bariatric surgery
• 6.8 Other surgery types

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals & clinics
• 7.3 Ambulatory surgical centers
• 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abbott
• 9.2 B. Braun
• 9.3 Becton, Dickinson and Company
• 9.4 Biorad Medisys
• 9.5 Boston Scientific
• 9.6 CONMED
• 9.7 FUJIFILM
• 9.8 Intuitive Surgical Operations
• 9.9 Johnson & Johnson MedTech
• 9.10 KARL STORZ
• 9.11 Medtronic
• 9.12 OLYMPUS
• 9.13 Smith + Nephew
• 9.14 Stryker
• 9.15 WEXLER SURGICAL
• 9.16 ZIMMER BIOMET